We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
F icon
651
Ford
F
$60.9B
$1.32M 0.01%
124,932
-14,673
-11% -$168K
ITT icon
652
ITT
ITT
$17.1B
$1.31M 0.01%
8,772
-277
-3% -$37.7K
CNQ icon
653
Canadian Natural Resources
CNQ
$96.9B
$1.3M 0.01%
39,238
+1,120
+3% +$39K
MAS icon
654
Masco
MAS
$14.6B
$1.3M 0.01%
15,488
+1,508
+11% +$114K
BG icon
655
Bunge Global
BG
$20.9B
$1.3M 0.01%
13,436
+105
+0.8% +$10.7K
O icon
656
Realty Income
O
$61.1B
$1.29M 0.01%
20,391
+837
+4% +$49.8K
XEL icon
657
Xcel Energy
XEL
$49.2B
$1.28M 0.01%
19,634
-45
-0.2% -$2.67K
PHG icon
658
Philips
PHG
$25.5B
$1.27M 0.01%
41,979
-8,707
-17% -$231K
OLED icon
659
Universal Display
OLED
$3.75B
$1.27M 0.01%
6,046
+97
+2% +$19.7K
FERG icon
660
Ferguson
FERG
$43.9B
$1.26M 0.01%
6,351
-6,780
-52% -$1.37M
SWX icon
661
Southwest Gas
SWX
$6.64B
$1.26M 0.01%
17,021
+2,572
+18% +$186K
PSA icon
662
Public Storage
PSA
$61.5B
$1.25M 0.01%
3,424
-4,857
-59% -$1.58M
WLKP icon
663
Westlake Chemical Partners
WLKP
$772M
$1.24M 0.01%
55,478
+10,000
+22% +$227K
WST icon
664
West Pharmaceutical
WST
$23.7B
$1.23M 0.01%
4,092
+79
+2% +$24.2K
HCA icon
665
HCA Healthcare
HCA
$90.6B
$1.23M 0.01%
3,022
+128
+4% +$46.9K
HESM icon
666
Hess Midstream
HESM
$5.19B
$1.22M 0.01%
34,700
-3,500
-9% -$128K
CNP icon
667
CenterPoint Energy
CNP
$28.3B
$1.22M 0.01%
41,518
-41,613
-50% -$1.16M
CADE
668
DELISTED
Cadence Bank
CADE
$1.22M 0.01%
38,295
+9,134
+31% +$283K
MTH icon
669
Meritage Homes
MTH
$4.78B
$1.22M 0.01%
11,858
+1,082
+10% +$102K
LKQ icon
670
LKQ Corp
LKQ
$6.72B
$1.22M 0.01%
30,447
+3,138
+11% +$129K
OSIS icon
671
OSI Systems
OSIS
$3.53B
$1.21M 0.01%
7,999
+354
+5% +$50.9K
SCHB icon
672
Schwab US Broad Market ETF
SCHB
$42.3B
$1.21M 0.01%
54,489
HSBC icon
673
HSBC
HSBC
$352B
$1.21M 0.01%
26,725
+2,782
+12% +$121K
AM icon
674
Antero Midstream
AM
$10.2B
$1.2M 0.01%
79,472
+20,124
+34% +$293K
FMC icon
675
FMC
FMC
$1.25B
$1.18M 0.01%
17,964
+91
+0.5% +$5.57K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.